重视新生血管性年龄相关性黄斑变性的个体化治疗
Optimizing the individual treatment of neovascular age-related macular degeneration
摘要
新生血管性年龄相关性黄斑变性(AMD)严重威胁老年人的视力.随着生命科学的迅速发展,新的治疗方法为新生血管性AMD患者带来希望.目前包括患者年龄、基线视力、病损特征及其基因在内的各种因素,已被用于预测AMD患者的治疗预后.在上述循证医学证据的基础上,我国及其他多个国家都更新了 AMD诊疗指南和诊疗路径,也规范了临床医师对患者进行准确诊断、全面评价和治疗的原则.但是由于患者病变特征不同,环境和基因背景等差异,还应注意为新生血管性AMD患者提供个体化治疗方案,这不仅有望使患者获得更好的治疗效果和更高的生活质量,而且也利于在我国逐渐进入老龄化社会的背景下,获得最佳的卫生经济学效益.
Neovascular age-related macular degeneration (AMD) is the major cause of visual impairment in elder people.The progress in biomedicine and the launch of new agents provide hope to the patients with AMD.Factors assoeiated with the response of AMD to treatment have been investigated,including the baseline visual acuity,age,the characteristics of the AMD lesions and the genotype of the patients,etc.Preferred Practice Pattern(R) guidelines are developed in different countries based on these evidences,which providet guidance for the pattern of practice,not for the care of a particular individual.To develop an evidence-based individual treatment strategy for the wet AMD patients,accurate and comprehensive evaluation are critical in initial visit and during the follow-up.Individual treatment strategy will not only benefit the patient with better visual outcome and higher quality of life,but also promote the best health economic efficiency for AMD treatment in our aging society.
Author:
SUN Xiao-dong
WANG Feng-hua
作者单位:
200080,上海交通大学医学院附属第一人民医院眼科
年,卷(期):
2012, 48(10)
分类号:
R246.82
机标分类号:
R77
R27
在线出版日期:
2012年12月27日